Clinical and laboratory-instrumental characteristics of patients with dyspepsia syndrome not associated with Нelicobacter pylori infection
- Authors: Bakulina N.V.1, Topalova Y.G.1, Tikhonov S.V.1
-
Affiliations:
- North-Western State Medical University named after I.I. Mechnikov
- Issue: Vol 16, No 3 (2024)
- Pages: 110-123
- Section: Original research
- URL: https://journal-vniispk.ru/vszgmu/article/view/271708
- DOI: https://doi.org/10.17816/mechnikov635377
- ID: 271708
Cite item
Abstract
BACKGROUND: The significant prevalence of dyspepsia in patients without Нelicobacter pylori infection, difficulties in differential diagnosis necessitate the identification of the most common nosological variants, optimization of the diagnosis algorithm.
AIM: To study clinical, laboratory and instrumental characteristics of patients with dyspepsia syndrome unrelated to Нelicobacter pylori infection.
MATERIALS AND METHODS: A 13C-Urea Breath test was performed to 856 patients with uninvestigated dyspepsia. According to its results, 342 patients with Нelicobacter pylori infection were excluded from the study. The remaining patients (n = 514) with negative Нelicobacter pylori status underwent esophagogastroduodenoscopy and ultrasound examination of the abdominal organs. The patients with an identified organic pathology (n = 129) explaining dyspeptic complaints were excluded from the study. 208 out of the 385 patients without organic pathology agreed to undergo laboratory and instrumental examination in accordance with the study protocol. To assess dyspeptic complaints, 208 patients filled out a “Dyspepsia Questionnaire” developed by the authors. Demographic, anthropometric data, and complaints were recorded in all the study participants; experimental psychological testing was performed (Beck’s questionnaires, generalized anxiety disorder questionnaire-7, Short Form-36) and laboratory and instrumental examination (the level of pepsinogen I, pepsinogen II, immunoglobulin class G to Нelicobacter pylori and gastrin-17 in serum), esophagogastrogastroduodenoscopy with biopsy and pathomorphological assessment according to the Operative Link for Gastritis Assessment (OLGA) system, 24-hour esophageal impedance–pH monitoring, radiography of the esophagus and stomach.
RESULTS: The majority of the patients with dyspepsia syndrome were not infected at the time of Нelicobacter pylori complaints — 514 (60.1%) patients. An in-depth examination of 208 people with a negative helicobacter status and the absence of an organic pathology explaining the symptoms revealed the heterogeneity of the final diagnoses. The results of the study demonstrate positive correlations between the level of depression, anxiety and the AET (acid exposure time) index, the number of acid reflux. A decrease in the level of pepsinogen I, gastrin-17, and the ratio of pepsinogen I/II was revealed with an increase in the degree and stage of atrophy according to the results of an Operative Link for Gastritis Assessment biopsy.
CONCLUSIONS: The revealed variability of diagnoses and comorbidity in patients with similar complaints deepens the understanding of dyspepsia syndrome and explains the possible ineffectiveness of standard therapy regimens.
Full Text
##article.viewOnOriginalSite##About the authors
Natalia V. Bakulina
North-Western State Medical University named after I.I. Mechnikov
Email: nv_bakulina@mail.ru
ORCID iD: 0000-0003-4075-4096
SPIN-code: 9503-8950
MD, Dr. Sci. (Medicine), Professor
Russian Federation, Saint PetersburgYulia G. Topalova
North-Western State Medical University named after I.I. Mechnikov
Author for correspondence.
Email: topalova.julias@yandex.ru
ORCID iD: 0000-0003-3999-6848
SPIN-code: 1301-6443
Russian Federation, Saint Petersburg
Sergey V. Tikhonov
North-Western State Medical University named after I.I. Mechnikov
Email: sergeyvt2702@gmail.com
ORCID iD: 0000-0001-5720-3528
MD, Cand. Sci. (Medicine), Assistant Professor
Russian Federation, Saint PetersburgReferences
- Ivashkin VT, Mayev IV, Sheptulin AA, et al. Diagnosis and treatment of the functional dyspepsia: clinical guidelines of the Russian Gastroenterological Association. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2017;27(1):50–61. EDN: ZIPAXX doi: 10.22416/1382-4376-2017-27-1-50-61
- Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466–1479. doi: 10.1053/j.gastro.2005.11.059
- McQuaid KR. Dyspepsia. In: Feldman M, Friedman LS, Brandt LJ, editors. Sleisenger and Fordtran’s gastrointestinal and liver. Philadelphia: Saunders Elsevier; 2006. P. 1–1540.
- Barberio B, Mahadeva S, Black CJ, et al. Systematic review with meta-analysis: global prevalence of uninvestigated dyspepsia according to the Rome criteria. Aliment Pharmacol Ther. 2020;52(5):762–773. doi: 10.1111/apt.16006
- Holtmann G, Talley NJ. Clinician’s manual on managing dyspepsia. London: Science Press; 2000. P. 88.
- Ivashkin VT, Sheptulin AA, Lapina TA, et al. Diagnosis and treatment of functional dyspepsia. Methodological recommendations for doctors. Moscow: RGA; 2011. P. 1–28. (In Russ.)
- Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study. Gastroenterology. 2021;160(1):99–114. doi: 10.1053/j.gastro.2020.04.014
- Li Y, Choi H, Leung K, et al. Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(6):553–564. doi: 10.1016/S2468-1253(23)00070-5
- Malfertheiner P, Megraud F, Rokkas T, et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022:gutjnl-2022-327745. doi: 10.1136/gutjnl-2022-327745
- Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64:33–67. doi: 10.1136/gutjnl-2015-309252
- Richter JE, Rubenstein JH. Presentation and epidemiology of gastroesophageal reflux disease. Gastroenterology. 2018;154(2):267–276. doi: 10.1053/j.gastro.2017.07.045
- Lee SW, Lee TY, Lien HC, et al. The risk factors and quality of life in patients with overlapping functional dyspepsia or peptic ulcer disease with gastroesophageal reflux disease. Gut Liver. 2014;8(2):160–164. doi: 10.5009/gnl.2014.8.2.160
- Kitapçioğlu G, Mandiracioğlu A, Caymaz Bor C, Bor S. Overlap of symptoms of dyspepsia and gastroesophageal reflux in the community. Turk J Gastroenterol. 2007;18(1):14–19.
- Lee SY, Lee KJ, Kim SJ, Cho SW. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study. Digestion. 2009;79(3):196–201. doi: 10.1159/000211715
- Noh YW, Jung HK, Kim SE, Jung SA. Overlap of erosive and nonerosive reflux diseases with functional gastrointestinal disorders according to Rome III criteria. JNeurogastroenterol Motil. 2010;16(2):148–156. doi: 10.5056/jnm.2010.16.2.148
- Drossman DA, Hasler WL. Rome IV — Functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016;150(6):1257–1261. doi: 10.1053/j.gastro.2016.03.035
- Sheptulin AA, Kardasheva SS, Kurbatova AA. Difficulties of differential diagnosis in functional dyspepsia. Clinical Medicine (Russian Journal). 2021;99(3):208–212. EDN: QFTBOW doi: 10.30629/0023-2149-2021-99-3-208-212
- Zaharova NV, Simanenkov VI, Bakulin IG, et al. Prevalence of Нelicobacter pylori infection in gastroenterological patients in Saint Petersburg. Pharmateka. 2016;(5S):33–39. EDN: XSDGAJ
- Richter P, Werner J, Heerlein A, et al. On the validity of the beck depression inventory. A review. Psychopathology. 1998;31(3):160–168. doi: 10.1159/000066239
- Zolotareva AA. Adaptation of the Russian version of the generalized anxiety disorder. Counseling Psychology and Psychotherapy. 2023;31(4(122)):31–46. EDN: WZVAPD doi: 10.17759/cpp.20230402
- Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder Arch Intern Med. 2006. Vol. 166, N 10. P. 1092–1097. doi: 10.1001/archinte.166.10.1092
- Brazier JE, Harper R, Jones NM, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305(6846):160–164. doi: 10.1136/bmj.305.6846.160
- Syrjanen K. A Panel of serum biomarkers (GastroPanel®) in non-invasive diagnosis of atrophic gastritis. Systematic review and meta-analysis. Anticancer Res. 2016;36(10):5133–5144. doi: 10.21873/anticanres.11083
- Syrjänen K, Eskelinen M, Peetsalu A, et al. GastroPanel® biomarker assay: The most comprehensive test for Helicobacter pylori infection and its clinical sequelae. A critical review. Anticancer Res. 2019;39(3):1091–1104. doi: 10.21873/anticanres.13218
- Adachi K, Kishi K, Notsu T, et al. Serum anti-Helicobacter pylori IgG antibody titer in H. pylori-negative cases with a different gastric mucosal atrophy status. Intern Med. 2020;59(22):2817–2823. doi: 10.2169/internalmedicine.5132-20
- Bakulina NV, Tikhonov SV, Savilova IV, et al. Dynamics of the prevalence of Helicobacter pylori infection from 2015 to 2023. Herald of North-Western State Medical University named after I.I. Mechnikov. 2023;15(3):41–51. EDN: ZCDOUQ doi: 10.17816/mechnikov623259
- Sheptulin AA, Rabotyagova YuS. The overlap of functional dyspepsia and gastroesophageal reflux disease: controversial and unresolved issue. Crimean Therapeutic Journal. 2020;(2):12–16. EDN: LRIYGH doi: 10.30629/0023-2149-2020-98-9-10-645-64
- Fukuda K, Kodama M, Mizukami K, et al. Analysis of long-term serological and histological changes after eradication of Helicobacter pylori. Clin Biochem Nutr. 2022;71(2):151–157. doi: 10.3164/jcbn.21-164
- Ivashkin VT, Maev IV, Lapina TL, et al. Clinical Recommendations of Russian Gastroenterological Association and RENDO Endoscopic Society on Diagnosis and Treatment of Gastritis and Duodenitis. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2021;(3(4)):70–99. EDN: CTXEBF doi: 10.22416/1382-4376-2021-31-4-70-99
- Chung SH, Lee KJ, Kim JY, et al. Association of the extent of atrophic gastritis with specific dyspeptic symptoms. J Neurogastroenterol Motil. 2015;21(4):528–536. doi: 10.5056/jnm15074
- Bakulina N, Tikhonov S, Malkov V, et al. Non-invasive screening of autoimmune atrophic gastritis in asymptomatic subjects by Serological Biomarker Test (GastroPanel®). Anticancer Res. 2022:42(3):1517–1526. doi: 10.21873/anticanres.15624
- Syrjanen K. Accuracy of Serum Biomarker Panel (GastroPanel®) in the diagnosis of atrophic gastritis of the corpus. Systematic review and meta-analysis. Anticancer Res. 2022;42(4):1679–1696. doi: 10.21873/anticanres.15645
- Huang Z, Wang K, Duan Y, Yang G. Correlation between lifestyle and social factors in functional dyspepsia among college freshmen. J Int Med Res. 2020;48(8):300060520939702. doi: 10.1177/0300060520939702
- Klausen KM, Bomme Høgh M, David M, et al. How dyspepsia, gastroesophageal reflux symptoms, and overlapping symptoms affect quality of life, use of health care, and medication — a long-term population based cohort study. Scand J Gastroenterol. 2021;56(7):753–760. doi: 10.1080/00365521.2021.1929448
- Grishechkina I. Gastroesophageal reflux disease: psychosomatic aspects. Pharmacy and Pharmacology. 2015;(S1):41–42. EDN: VFXHXF
- Spasova TE, Grigorieva EV. Gender peculiarities of gastroesophageal reflux disease. Acta Biomedica Scientifica. 2015;(2(102)):38–41. EDN: UCKKUR
Supplementary files
